Stay tuned

Correlation between the recovery of certain innate immune lymphoid cells and the occurrence of GvHD after hematopoietic stem cell transplantation. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Piperoglou C, Larid...

Members of the CRYOSTEM network were all invited on Wednesday November 18 to participate in the annual meeting of the Plenary Committee. The opportunity for participants to take stock of the national cohort and discuss the ongoing valorization actions of the collection.

CRYOSTEM and Modul-Bio are presenting a poster at the ISBER 2020 virtual symposium as part of the management of the CRYO-LEA * cohort using the MBioLIMS BioBanking® software. Launched in 2018, the CRYO-LEA cohort allows the valuation of epidemiological and clinical...

Inserm is now launching a platform for evaluating vaccine candidates. The planned clinical trials are on an unprecedented scale in France. Visit the COVIREIVAC platform website

Check Abstract A103 on the #EBMT20Virtual e-poster area Background : Even if Chimeric Antigen Receptor (CAR)-T cells therapies are a promising way to treat relapsed/refractory hematologic cancers, authorities face major issues regarding their economic impact, the...

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge - AUGUST 20, 2020 “Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD”. Blood Adv...

Robert, E., Fontenille, C., Dalle, J.-H., de Latour, R.P. and Calmels, B., 2020. “CRYOSTEM Biobank: A National Prospective, Standardized Collection to Better Characterize Allogeneic Hematopoietic Stem Cell Transplantation Complications”. Open Journal of Bioresources,...

CRYOSTEM is launching its annual call for projects on the thematic of HSCT complications. Access to the unique European biological resources collection of transplanted patients enabling you to validate preliminary results on larger cohorts or to support the discovery...

CRYOSTEM teams up with CALYM (a Carnot institute devoted to Lymphoma) to develop a new biological resources collection (blood, stools and urines) of patients suffering from lymphoma and treated by CAR-T cells. This collection of high clinical and biological value will...

#GVHD research & scientific valorization. Publication of a promising study led by Dr David Michonneau & using the CRYOSTEM collection to validate the reliability of experimental data.  https://go.nature.com/2RPcX2q